Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 4;162:D2408.

[Gastrografin as a Prognostic and Therapeutic Medium; Use for Small Bowel Obstruction, but Not for Closed Loop Obstruction]

[Article in Dutch]
Affiliations
  • PMID: 30040276

[Gastrografin as a Prognostic and Therapeutic Medium; Use for Small Bowel Obstruction, but Not for Closed Loop Obstruction]

[Article in Dutch]
Ariane A van Loevezijn et al. Ned Tijdschr Geneeskd. .

Abstract

Timely recognition and treatment of small bowel obstruction is of great importance for the course of the disease. Complete obstruction of the small bowel can lead to serious complications such as bowel ischaemia and perforation. Gastrografin, which is traditionally used as an oral contrast agent in imaging diagnostics, is of prognostic and therapeutic value in patients presenting with adhesive small bowel obstruction. CT is necessary to rule out closed loop obstruction or other than adhesive causes of the bowel obstruction before using Gastrografin. Patients with closed loop obstruction can rapidly develop bowel ischaemia and immediate surgery is indicated once diagnosed. Awaiting clinical resolution of the small bowel obstruction without surgery is justified when closed loop obstruction has been ruled out, there are no signs of bowel ischaemia and an abdominal radiograph within 4-24 hours after administration of Gastrografin shows the oral contrast in the colon.

Similar articles

See all similar articles

MeSH terms

LinkOut - more resources

Feedback